PTPI Petros Pharmaceuticals Inc

USD 1.45 -0.10 -6.451613
Icon

Petros Pharmaceuticals Inc (PTPI) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | NSD
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 1.45

-0.10 (-6.45)%

USD 3.46M

0.76M

USD 4.00(+175.86%)

USD 2.47 (+70.34%)

Icon

PTPI

Petros Pharmaceuticals Inc (USD)
COMMON STOCK | NSD
USD 1.45
0.00 0
Take a Tour
stockTargetAdvisor

Strong Buy

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

Strong Buy

Average User
Rating

USD 3.46M

USD 2.47 (+70.34%)

USD 1.45

Petros Pharmaceuticals Inc (PTPI) Stock Forecast

USD 4.00
(+175.86%)

Based on the Petros Pharmaceuticals Inc stock forecast from 1 analysts, the average analyst target price for Petros Pharmaceuticals Inc is USD 4.00 over the next 12 months. Petros Pharmaceuticals Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Petros Pharmaceuticals Inc is Bearish, which is based on 2 positive signals and 7 negative signals. At the last closing, Petros Pharmaceuticals Inc’s stock price was USD 1.45. Petros Pharmaceuticals Inc’s stock price has changed by +2.84% over the past week, -12.65% over the past month and -0.34% over the last year.

No recent analyst target price found for Petros Pharmaceuticals Inc
No recent average analyst rating found for Petros Pharmaceuticals Inc

Company Overview Petros Pharmaceuticals Inc

Petros Pharmaceuticals, Inc., a pharmaceutical company, focuses on men's health therapeutics in the United States and internationally. It operates through two segments, Prescription Medications and Medical Devices. The company engages in the commercialization and development of S...Read More

1185 Avenue of the Americas, New York, NY, United States, 10036

24

December

USD

USA

Adjusted Closing Price for Petros Pharmaceuticals Inc (PTPI)

Loading...

Unadjusted Closing Price for Petros Pharmaceuticals Inc (PTPI)

Loading...

Share Trading Volume for Petros Pharmaceuticals Inc Shares

Loading...

Compare Performance of Petros Pharmaceuticals Inc Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for PTPI

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To Petros Pharmaceuticals Inc (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
VTRS
Viatris Inc +0.23 (+1.98%) USD14.11B 237.70 8.88

ETFs Containing PTPI

Symbol Name PTPI's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About Petros Pharmaceuticals Inc (PTPI) Stock

Based on ratings from 1 analysts Petros Pharmaceuticals Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Bearish. The stock has 1 buy, sell and hold ratings.

Unfortunately we do not have enough data on PTPI's stock to indicate if its a good dividend stock.

Based on targets from 1 analysts, the average taret price for PTPI is USD 4.00 over the next 12 months. The maximum analyst target price is USD 4 while the minimum anlayst target price is USD 4.

Unfortunately we do not have enough data on PTPI's stock to indicate if its overvalued.

The last closing price of PTPI's stock was USD 1.45.

The most recent market capitalization for PTPI is USD 3.46M.

Based on targets from 1 analysts, the average taret price for PTPI is projected at USD 4.00 over the next 12 months. This means that PTPI's stock price may go up by +175.86% over the next 12 months.

We can't find any ETFs which contains Petros Pharmaceuticals Inc's stock.

As per our most recent records Petros Pharmaceuticals Inc has 24 Employees.

Petros Pharmaceuticals Inc's registered address is 1185 Avenue of the Americas, New York, NY, United States, 10036. You can get more information about it from Petros Pharmaceuticals Inc's website at https://www.petrospharma.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...